Gregory T. Sloma
Director/Miembro de la Junta en Financial Transmission Network, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kurt M. Matis | M | - |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | 17 años |
William E. Fisher | M | 77 |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | 10 años |
Martin Massengale | M | 90 |
University of Nebraska
| 48 años |
Matthew Nord | M | 44 | 9 años | |
John Williams | M | - |
Drake-Williams Steel, Inc.
Drake-Williams Steel, Inc. Engineering & ConstructionIndustrial Services Drake-Williams furnishes fabricated structural steel, stair systems and miscellaneous fabricated steel, steel joist/deck, and fabricated concrete reinforcing steel, for all types of building projects. Its ample facilities, modern equipment, and experienced people ensure a successful project, furnished to customer specifications and delivered on time. Drake-Williams also provides contract manufacturing services involving the fabrication of diverse steel components and assemblies for incorporation into customer products and facilities. Additionally, its Steel Service Center furnishes stock sized and processed steel to customers in its local geographical area. Its Service Center customers receive immediate attention to their needs, including quick order turnaround and delivery. Drake-Williams is certified by the AISC ('American Institute of Steel Construction') Quality Certification Program. | - |
David W. Williams | M | - |
Drake-Williams Steel, Inc.
Drake-Williams Steel, Inc. Engineering & ConstructionIndustrial Services Drake-Williams furnishes fabricated structural steel, stair systems and miscellaneous fabricated steel, steel joist/deck, and fabricated concrete reinforcing steel, for all types of building projects. Its ample facilities, modern equipment, and experienced people ensure a successful project, furnished to customer specifications and delivered on time. Drake-Williams also provides contract manufacturing services involving the fabrication of diverse steel components and assemblies for incorporation into customer products and facilities. Additionally, its Steel Service Center furnishes stock sized and processed steel to customers in its local geographical area. Its Service Center customers receive immediate attention to their needs, including quick order turnaround and delivery. Drake-Williams is certified by the AISC ('American Institute of Steel Construction') Quality Certification Program. | - |
Jay Stewart | M | - |
Drake-Williams Steel, Inc.
Drake-Williams Steel, Inc. Engineering & ConstructionIndustrial Services Drake-Williams furnishes fabricated structural steel, stair systems and miscellaneous fabricated steel, steel joist/deck, and fabricated concrete reinforcing steel, for all types of building projects. Its ample facilities, modern equipment, and experienced people ensure a successful project, furnished to customer specifications and delivered on time. Drake-Williams also provides contract manufacturing services involving the fabrication of diverse steel components and assemblies for incorporation into customer products and facilities. Additionally, its Steel Service Center furnishes stock sized and processed steel to customers in its local geographical area. Its Service Center customers receive immediate attention to their needs, including quick order turnaround and delivery. Drake-Williams is certified by the AISC ('American Institute of Steel Construction') Quality Certification Program. | - |
Blake A. Mertens | M | 46 |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | - |
Chris Pudenz | M | - |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | - |
Brian Grier | M | - |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | - |
Christopher Wikoff | M | 49 | 8 años | |
Chris Thompson | M | - |
Financial Transmission Network, Inc.
Financial Transmission Network, Inc. Packaged SoftwareTechnology Services Financial Transmission Network, Inc. develops integrated and automated payment solution. Its platform ETran, integrates receivable and accepts any payment methods via payment channel on a single, secure, cloud-based platform by banking and financial services, distribution, insurance, nonprofit, property management and utilities industries. The company was founded by Kurt M. Matis in 2007 and is headquartered in Omaha, NE. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Brett Frevert | M | 61 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 2 años |
Craig J. Tuttle | M | 71 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 7 años |
Robert M. Patzig | M | 55 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Debra Ann Schneider | F | 65 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Rockford G. Meyer | M | - |
Creighton University
University of Nebraska
| 7 años |
Eugenia Marie Simpson | F | - |
University of Nebraska
| 6 años |
Nicole Theophilus | F | 54 | 2 años | |
Chad M. Richards | M | 54 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 6 años |
Jan Madsen | F | 61 | - | |
Laura Grattan | F | 42 | 5 años | |
Anthony J. DiNovi | M | 61 | 11 años | |
James H. Strong | M | - |
University of Nebraska
| 7 años |
Mark D. Theisen | M | - |
Creighton University
University of Nebraska
| 7 años |
Barry Ballou | M | - |
University of Nebraska
| 6 años |
Paul M. Mendlik | M | 70 | 13 años | |
Doit L. Koppler | M | 61 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 7 años |
Michael A. Huber | M | 55 | 3 años | |
Jeff Swenson | M | 48 | 6 años | |
Rodney Markin | M | 67 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 7 años |
Steven M. Stangl | M | 65 | - | |
Don Casey | M | 64 | 2 años | |
Lee Adrean | M | 72 | 3 años | |
Michael Summers | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Paul Garcia | M | 71 | 4 años | |
Jeanette Horan | F | 69 | 1 años | |
Antonius P. Schuh | M | 59 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 5 años |
Gregory Wells | M | 67 |
University of Nebraska
| 5 años |
Mitchell L. Murphy | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Gregory J. Duman | M | 69 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE.
University of Nebraska
| 14 años |
Michael Draper | M | 58 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 4 años |
Matthew West Yost | M | - | 5 años | |
Diane Offereins | F | 66 | 2 años | |
Mazen Alnaimi | M | - |
University of Nebraska
| 4 años |
Stephen V. Glenn | M | - |
University of Nebraska
| 4 años |
Richard M. Poppe | M | - |
University of Nebraska
| 4 años |
Cynthia Susan Hahn | F | - |
University of Nebraska
| 4 años |
Michael Murman | M | - |
University of Nebraska
| 4 años |
Caroline J. Miller | F | - |
University of Nebraska
| 4 años |
John Dinovo | M | - |
University of Nebraska
| 4 años |
Bill Shreve | M | - |
University of Nebraska
| 4 años |
Rick Villars | M | - |
University of Nebraska
| 6 años |
David E. Morrison | M | - |
University of Nebraska
| 4 años |
Patrick L. Pope | M | - |
University of Nebraska
| 4 años |
Tom Osborne | M | - |
University of Nebraska
| 40 años |
Dick Poppe | M | - |
University of Nebraska
| 4 años |
Thomas M. Galvin | M | - |
University of Nebraska
| 4 años |
Stan Walker | M | - |
University of Nebraska
| 4 años |
Kerry McGrath | M | - |
University of Nebraska
| 4 años |
Dan C. McPhail | M | - |
University of Nebraska
| 4 años |
Edward Conrath | M | - |
University of Nebraska
| 4 años |
Myles James Watts | M | 73 |
University of Nebraska
| 3 años |
Michael B. Spiegel | M | - |
University of Nebraska
| 4 años |
Eric Johnson | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 1 años |
James F. Burke | M | - |
University of Nebraska
| 3 años |
Jeffrey J. Prosser | M | - |
University of Nebraska
| 4 años |
David Kemp Karnes | M | - |
University of Nebraska
| 3 años |
Bruce McClatchey | M | - |
University of Nebraska
| 4 años |
Dan Norman | M | 65 |
University of Nebraska
| 4 años |
John Wilson | M | 68 |
University of Nebraska
| 4 años |
James A. Barnes | M | 69 |
University of Nebraska
| 4 años |
Scott A. Brittenham | M | 65 |
University of Nebraska
| 4 años |
Brian Larson | M | - |
DTN, Inc.
DTN, Inc. Internet Software/ServicesTechnology Services DTN, Inc. provides on-line agricultural market information. The company's flagship product, DTN Marketspace, links buyers and sellers of grain by providing a secure online marketplace to identify marketing opportunities, transact business, and manage positions and commitments. It offers its products to the agriculture, refined fuels, commodities and futures trading, public safety, aviation, turf, recreation, construction and transportation industries. DTN was founded in 1984 and is headquartered in Omaha, NE. | 9 años |
Timothy M. Hascall | M | 69 |
University of Nebraska
| 4 años |
Michael M. Sturgeon | M | 62 | - | |
Collin J. D'Silva | M | 67 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 10 años |
Jeffrey L. Sklar | M | 76 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 13 años |
Roland J. Santoni | M | - |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Dennis Nelson | M | 74 |
University of Nebraska
| 4 años |
David A. Roehr | M | 66 |
University of Nebraska
| 4 años |
William Lester | M | - |
University of Nebraska
| 4 años |
Mark Borer | M | 70 |
University of Nebraska
| 4 años |
Don R. Bouc | M | - |
University of Nebraska
| 1 años |
Steve Lococo | M | 67 |
University of Nebraska
| 4 años |
Radha Lai | F | - |
University of Nebraska
| 4 años |
Parag Phoolchand Saxena | M | 69 |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Randy D. Greer | M | 72 |
University of Nebraska
| 4 años |
Ronald Greeno | M | - |
University of Nebraska
| 3 años |
Randy K. Rouse | M | - |
University of Nebraska
| 4 años |
Garry Busboom | M | - |
University of Nebraska
| 4 años |
Stephen Kerns | M | - |
University of Nebraska
| 4 años |
David A. Jacobson | M | - |
University of Nebraska
| 3 años |
Ed Vigna | M | - |
University of Nebraska
| 4 años |
Homer L. Harris | M | - |
University of Nebraska
| 4 años |
Michael Prosser | M | - |
University of Nebraska
| 4 años |
Richard B. Williams | M | - |
University of Nebraska
| 4 años |
Mark L. Johnson | M | - |
University of Nebraska
| 4 años |
Marvin P. Ehly | M | 70 |
University of Nebraska
| 4 años |
Doug Weedin | M | - |
University of Nebraska
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Gregory T. Sloma
- Red Personal